Lupin subsidiary inks pact to acquire Netherlands-based VISUfarma

Lupin's subsidiary will acquire VISUfarma BV for 190 million euros. This expands Lupin's European business and eye health product range. The acquisition strengthens Lupin's specialty franchise. It will enter the ophthalmology market. The deal is expected to close by late 2025. This transaction will enhance Lupin's growth and margin profile.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/CniF2oE
via IFTTT